abstract |
The present disclosure relates to, inter alia, stable formulations comprising an antibody that binds human CD 137 or antigen binding fragments thereof, and to use of the formulations in methods for treating, or ameliorating various diseases and conditions, including cancer, that are amenable to treatment with a CD 137 antibody. |